Australia Sepsis Study To Aid In New Antibiotic Discovery
Researchers from the University of Queensland in Australia have led a national study pertaining to four major bacteria that cause sepsis, thereby providing new...
COVID-19 Hospitalisation Dips Using Monoclonal Antibodies
A study has gone on to find that monoclonal antibodies (mAbs) decreased the risk of hospitalisation or even death by 39% if given within...
AI Assesses The Enzyme Functions Finer Than Leading Tools
A novel artificial intelligence tool can help predict the functions of enzymes on the basis of their amino acid sequences, even when the enzymes...
Regulatory Actions Needed For Gaps In Cancer Drug Info
Drug manufacturers are not able to provide Europeans with the required information to gauge the benefits and defects of oncology medicines. This is as...
A Fund Boost For World-First Nervous System Transplant Study
Griffith University, based in Australia, has gone on to conduct a world-first study when it comes to cell transplantation so as to repair nervous...
New Delivery Path Brings To Light Efficacy of Immunotherapy
Intrathecal (IT), intravenous (IV), and Nivolumab (anti-PD-1) immunotherapy were found to be safe and prolong life in a subset of melanoma individuals with leptomeningeal...
£277m Funding Set To Benefit UK Life Sciences Manufacturing
A £277 million joint government-industry finance package will assist four UK life sciences companies in moving forward with life sciences manufacturing initiatives.
The Life Sciences...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...